Holen Sie sich die Stockscreener-App
2.85
0.35%
-0.010
Handel nachbörslich:
2.85
Schlusskurs vom Vortag:
$2.86
Offen:
$2.96
24-Stunden-Volumen:
566.54K
Relative Volume:
1.01
Marktkapitalisierung:
$106.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.95%
1M Leistung:
+53.23%
6M Leistung:
+92.57%
1J Leistung:
+45.41%
1-Tages-Spanne:
$2.73
$3.02
1-Wochen-Bereich:
$2.71
$3.28
52-Wochen-Spanne:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Vergleichen Sie MGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.85 | 107.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
Will Metagenomi Inc. stock go up soon2025 Big Picture & Reliable Intraday Trade Plans - newser.com
Using Ichimoku Cloud for Metagenomi Inc. technicals2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Chart overlay techniques for tracking Metagenomi Inc.July 2025 Momentum & Community Consensus Picks - newser.com
Will Metagenomi Inc. stock see insider buyingBull Run & Safe Capital Growth Plans - newser.com
Metagenomi's (MGX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What candlestick patterns are forming on Metagenomi Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
What recovery options are there for Metagenomi Inc.Market Rally & Long-Term Growth Stock Strategies - newser.com
Measuring Metagenomi Inc.’s beta against major indicesTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
How Metagenomi Inc. stock performs in rate cut cyclesWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
Why Metagenomi Inc. stock could outperform in 20252025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Custom watchlist performance reports with Metagenomi Inc.Quarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Detecting support and resistance levels for Metagenomi Inc.July 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Best data tools to analyze Metagenomi Inc. stockEarnings Recap Summary & Community Supported Trade Ideas - newser.com
Why Metagenomi Inc. stock could be next big winner2025 Volume Leaders & Community Verified Watchlist Alerts - newser.com
Metagenomi (NASDAQ:MGX) versus SCYNEXIS (NASDAQ:SCYX) Head-To-Head Analysis - Defense World
What technical signals suggest for Metagenomi Inc. stockJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Can you recover from losses in Metagenomi Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Metagenomi, Inc. Enters into A Non-Exclusive License Agreement with Acuitas Therapeutics, Inc - MarketScreener
Goldman Sachs Group Inc. Trims Stock Position in Metagenomi, Inc. $MGX - Defense World
Finanzdaten der Metagenomi Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):